Anti-NFkB p105 / p50抗体(ab55560)


  • 产品名称Anti-NFkB p105 / p50抗体
    参阅全部 NFkB p105 / p50 一抗
  • 描述
    小鼠单克隆抗体to NFkB p105 / p50
  • 经测试应用适用于: WB, IHC-Pmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    Recombinant fragment, corresponding to amino acids 860-969 of Human NFkB p105/ p50



Our Abpromise guarantee covers the use of ab55560 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
  • 应用说明WB: Use at a concentration of 1-5 µg/ml.
    IHC-P: Use at a concentration of 3 µg/ml.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • 靶标

    • 功能NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.
    • 序列相似性Contains 7 ANK repeats.
      Contains 1 death domain.
      Contains 1 RHD (Rel-like) domain.
    • 结构域The C-terminus of p105 might be involved in cytoplasmic retention, inhibition of DNA-binding, and transcription activation.
      Glycine-rich region (GRR) appears to be a critical element in the generation of p50.
    • 翻译后修饰While translation occurs, the particular unfolded structure after the GRR repeat promotes the generation of p50 making it an acceptable substrate for the proteasome. This process is known as cotranslational processing. The processed form is active and the unprocessed form acts as an inhibitor (I kappa B-like), being able to form cytosolic complexes with NF-kappa B, trapping it in the cytoplasm. Complete folding of the region downstream of the GRR repeat precludes processing.
      Phosphorylation at 'Ser-903' and 'Ser-907' primes p105 for proteolytic processing in response to TNF-alpha stimulation. Phosphorylation at 'Ser-927' and 'Ser-932' are required for BTRC/BTRCP-mediated proteolysis.
      Polyubiquitination seems to allow p105 processing.
      S-nitrosylation of Cys-61 affects DNA binding.
    • 细胞定位Nucleus. Cytoplasm. Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor.
    • Information by UniProt
    • 数据库链接
    • 别名
      • DKFZp686C01211 antibody
      • DNA binding factor KBF1 antibody
      • DNA binding factor KBF1 EBP1 antibody
      • DNA-binding factor KBF1 antibody
      • EBP 1 antibody
      • EBP-1 antibody
      • EBP1 antibody
      • KBF1 antibody
      • MGC54151 antibody
      • NF kappa B antibody
      • NF kappaB antibody
      • NF kappabeta antibody
      • NF kB1 antibody
      • NFkappaB antibody
      • NFKB 1 antibody
      • NFKB p105 antibody
      • NFKB p50 antibody
      • Nfkb1 antibody
      • NFKB1_HUMAN antibody
      • Nuclear factor kappa B DNA binding subunit antibody
      • Nuclear factor kappa-B, subunit 1 antibody
      • Nuclear factor NF kappa B p105 subunit antibody
      • Nuclear factor NF kappa B p50 subunit antibody
      • Nuclear factor NF-kappa-B p50 subunit antibody
      • Nuclear factor of kappa light chain gene enhancer in B cells 1 antibody
      • Nuclear factor of kappa light polypeptide gene enhancer in B cells 1 antibody
      • Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 antibody
      • p105 antibody
      • p50 antibody
      • p84/NF-kappa-B1 p98 antibody
      • Transcription factor NFKB1 antibody
      see all

    Anti-NFkB p105 / p50 antibody 图像

    • NFkB p105 / p50 antibody (ab55560) used in immunohistochemistry at 3ug/ml on formalin fixed and paraffin embedded human salivary gland.

    • Predicted band size : 105 kDa
      NFkB p105 / p50 antibody (ab55560) at 1ug/lane + HeLa cell lysate at 25ug/lane.

    Anti-NFkB p105 / p50 antibody (ab55560)参考文献

    ab55560 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab55560.
    Please use the links above to contact us or submit feedback about this product.